Kezar Life Sciences’ Risk Disclosures Rely on Cross-References, Potentially Obscuring Full Risk Picture for InvestorsTip Ranks·May 12 at 01:01 AMKZR0.00%SBIO+3.26%
Aurinia Pharmaceuticals Completes Acquisition of Kezar Life SciencesTip Ranks·May 11 at 08:59 AMAUPH-1.19%KZR0.00%
Kevin Tang named CEO of Kezar Life Sciences as multiple directors and officers resignTradingView·May 11 at 08:33 AMKZR0.00%
Kezar Life Sciences Announced Transfer or Voluntary Withdrawal of ListingTradingView·May 11 at 08:33 AMKZR0.00%XBI+2.40%
Kezar Life Sciences, Inc. (NASDAQ:KZR) Given Consensus Recommendation of "Reduce" by AnalystsMarket Beat·May 5 at 03:12 AMKZR0.00%ARKG+4.69%
16:13 ETAre KZR, EQH, ULYX Obtaining Fair Deals for their Shareholders?prnewswire·Apr 14 at 03:14 PMULY0.00%EQH+1.10%
13:34 ETAre APLS, CNTA, KZR Obtaining Fair Deals for their Shareholders?prnewswire·Apr 10 at 12:35 PMFBT+0.87%IHE-1.00%
14:15 ETSHAREHOLDER ALERT: The M&A Class Action Firm Is Investigating The Merger--KZR, CNTA, AFBI, and APLSprnewswire·Apr 8 at 01:17 PMIBB+0.76%ARKG+4.69%
Are KZR, TALK, WBD Obtaining Fair Deals for their Shareholders? | KZR Stock NewsStockTitan·Apr 7 at 05:47 AMWBD-0.66%UHS-2.90%
Kezar Life Sciences Announces Major Executive Leadership ChangesTip Ranks·Apr 3 at 04:27 PMLABU+7.13%ARKG+4.69%
Aurinia Pharmaceuticals to Acquire Kezar, Expanding Autoimmune PipelineTip Ranks·Apr 3 at 04:22 PMXBI+2.40%KZR0.00%
